Inflammatory bowel disease and celiac disease: overlaps and differences.
暂无分享,去创建一个
C. Núñez | Concepción Núñez | Virginia Pascual | Romina Dieli-Crimi | Natalia López-Palacios | Andrés Bodas | Luz María Medrano | L. Medrano | N. López-Palacios | R. Dieli-crimi | V. Pascual | A. Bodas | R. Dieli-Crimi
[1] An Carbonez,et al. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. , 2003, The New England journal of medicine.
[2] G. Holmes,et al. Association of coeliac disease and inflammatory bowel disease. , 1980, Gut.
[3] V. Annese,et al. Prevalence of celiac disease in inflammatory bowel diseases: An IG-IBD multicentre study. , 2010, Digestive and Liver Disease.
[4] A. Neugut,et al. Characteristics of adult celiac disease in the USA: results of a national survey , 2001, American Journal of Gastroenterology.
[5] Virgínia Lúcia Ribeiro-Cabral,et al. Anti-tissue transglutaminase antibodies (IgA and IgG) in both Crohn´s disease and autoimmune diabetes. , 2011, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.
[6] Sarah Edkins,et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease , 2011, Nature Genetics.
[7] P. Adibi,et al. Serologic celiac disease in patients with inflammatory bowel disease , 2012, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.
[8] P. Lakatos,et al. Smoking in inflammatory bowel diseases: good, bad or ugly? , 2007, World journal of gastroenterology.
[9] A. Moss,et al. Infliximab for induction and maintenance therapy for ulcerative colitis. , 2006, Gastroenterology.
[10] C. Mulder,et al. Refractory coeliac disease. , 2005, Best practice & research. Clinical gastroenterology.
[11] K. Giersiepen,et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease , 2012, Journal of pediatric gastroenterology and nutrition.
[12] Donatella,et al. A Meta-Analysis of Genome-Wide Association Scans Identifies IL18RAP, PTPN2, TAGAP, and PUS10 As Shared Risk Loci for Crohn's Disease and Celiac Disease , 2011, PLoS genetics.
[13] T. Hibi,et al. Appendectomy protects against the development of ulcerative colitis and reduces its recurrence: results of a multicenter case-controlled study in Japan , 2001, American Journal of Gastroenterology.
[14] M. Cottone,et al. FAMILIAL ASSOCIATION OF CROHN'S AND COELIAC DISEASES , 1989, The Lancet.
[15] B. Dema,et al. Th17-Related Genes and Celiac Disease Susceptibility , 2012, PloS one.
[16] L. Greco,et al. The first large population based twin study of coeliac disease , 2002, Gut.
[17] M. Olandoski,et al. Antibodies anti-Saccharomyces cerevisiae (ASCA) do not differentiate Crohn's disease from celiac disease. , 2010, Arquivos de gastroenterologia.
[18] C. Åhrén,et al. Chronic inflammatory bowel disease in patients with coeliac disease. , 1982, Scandinavian journal of gastroenterology.
[19] P. Rutgeerts,et al. Safety and tolerability of antagonist anti‐human CD40 Mab ch5D12 in patients with moderate to severe Crohn's disease , 2005, Alimentary pharmacology & therapeutics.
[20] C. Neut,et al. Dysbiosis as a prerequisite for IBD. , 2004, Gut.
[21] K. Kaukinen,et al. The Duodenal Microbiota Composition of Adult Celiac Disease Patients Is Associated with the Clinical Manifestation of the Disease , 2013, Inflammatory bowel diseases.
[22] Jorma Ilonen,et al. Prevalence of Celiac disease among children in Finland. , 2003, The New England journal of medicine.
[23] D. Coggon,et al. Inflammatory bowel disease and domestic hygiene in infancy , 1994, The Lancet.
[24] J. Hugot,et al. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria. , 2005, Journal of pediatric gastroenterology and nutrition.
[25] A. Tursi,et al. High Prevalence of Celiac Disease Among Patients Affected by Crohn's Disease , 2005, Inflammatory bowel diseases.
[26] J. Murray,et al. Review article: coeliac disease, new approaches to therapy , 2012, Alimentary pharmacology & therapeutics.
[27] Jaume Bertranpetit,et al. A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300 , 2012, Gut.
[28] B. Messing,et al. A severe but reversible refractory sprue , 2005, Gut.
[29] A. Neugut,et al. Inflammatory Bowel Disease in Patients with Celiac Disease , 2005, Inflammatory bowel diseases.
[30] P. Rutgeerts,et al. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. , 2006, Gastroenterology.
[31] P. Green,et al. Epidemiology and clinical presentations of celiac disease , 2012, Seminars in Immunopathology.
[32] S. Targan,et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. , 1997, The New England journal of medicine.
[33] T. Hibi,et al. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. , 2004, Gastroenterology.
[34] L. Fugger,et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease , 1998, Nature Medicine.
[35] S. Ng,et al. Characterization of the Gastrointestinal Microbiota in Health and Inflammatory Bowel Disease , 2012, Inflammatory bowel diseases.
[36] C. Mulder,et al. Azathioprine and prednisone combination therapy in refractory coeliac disease , 2003, Alimentary pharmacology & therapeutics.
[37] L. Ciobanu,et al. Unknown complicated celiac disease as an unexpected finding in patients investigated with capsule endoscopy for Crohn's disease. A case series. , 2013, Journal of gastrointestinal and liver diseases : JGLD.
[38] L. Nyström,et al. The Swedish coeliac disease epidemic with a prevailing twofold higher risk in girls compared to boys may reflect gender specific risk factors , 2002, European Journal of Epidemiology.
[39] M. Ament,et al. Celiac sprue and Crohn's disease: an association causing severe growth retardation. , 1977, Gastroenterology.
[40] E. Seidman,et al. Guideline for the Diagnosis and Treatment of Celiac Disease in Children : Recommendations of the North American Society for Pediatric Gastroenterology , Hepatology and Nutrition , 2004 .
[41] E. Macintyre,et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma , 2000, The Lancet.
[42] A. Doria,et al. IgA and IgG Tissue Transglutaminase Antibody Prevalence and Clinical Significance in Connective Tissue Diseases, Inflammatory Bowel Disease, and Primary Biliary Cirrhosis , 2003, Digestive Diseases and Sciences.
[43] B. V. von Blomberg,et al. Cladribine therapy in refractory celiac disease with aberrant T cells. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[44] H. Freeman,et al. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. , 2012, World journal of gastroenterology.
[45] A. Caminero,et al. Differences of small intestinal bacteria populations in adults and children with/without celiac disease: Effect of age, gluten diet, and disease , 2012, Inflammatory bowel diseases.
[46] G. Martorana,et al. Familial occurrence of inflammatory bowel disease in celiac disease. , 2003 .
[47] S. Hanauer,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[48] J. Dahm,et al. [Celiac disease in the adult--a case report]. , 1991, Zeitschrift für Gastroenterologie - German Journal of Gastroenterology.
[49] C. Lowry,et al. Hygiene and other early childhood influences on the subsequent function of the immune system , 2012, Brain Research.
[50] A. Salas,et al. The prevalence of coeliac disease is significantly higher in children compared with adults , 2011, Alimentary pharmacology & therapeutics.
[51] O. Lohi,et al. Increasing prevalence of coeliac disease over time , 2007, Alimentary pharmacology & therapeutics.
[52] J. Cosnes. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. , 2004, Best practice & research. Clinical gastroenterology.
[53] A. Ananthakrishnan. Environmental risk factors for inflammatory bowel disease. , 2013, Gastroenterology & hepatology.
[54] K. Helzlsouer,et al. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974 , 2010, Annals of medicine.
[55] G. Lichtenstein. Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial , 2008 .
[56] D. MacArthur,et al. Negligible impact of rare autoimmune-locus coding-region variants on missing heritability , 2013, Nature.
[57] V. Kuchroo,et al. Induction and effector functions of TH17 cells , 2008, Nature.
[58] C. Catassi. [The global village of celiac disease]. , 2008, Recenti progressi in medicina.
[59] W. Verbeek,et al. The Management of Complicated Celiac Disease , 2007, Digestive Diseases.
[60] D. Jewell,et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease , 1996, The Lancet.
[61] Cisca Wijmenga,et al. A Meta-Analysis of Genome-Wide Association Scans Identifies IL18RAP, PTPN2, TAGAP, and PUS10 As Shared Risk Loci for Crohn's Disease and Celiac Disease , 2011, PLoS genetics.
[62] Giuseppe Leone,et al. Environmental risk factors for MDS/AML , 2009 .
[63] B. Božič,et al. Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value , 2010, Wiener klinische Wochenschrift.
[64] R. Sartor. The influence of normal microbial flora on the development of chronic mucosal inflammation. , 1997, Research in immunology.
[65] Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. , 2005, Archives of disease in childhood.
[66] D. Ardid,et al. Immunopathogenesis of inflammatory bowel disease. , 2010, Self/nonself.
[67] P. Marques‐Vidal,et al. Impact of Disease and Treatments on Growth and Puberty of Pediatric Patients with Inflammatory Bowel Disease , 2012, Digestion.
[68] S. Montgomery,et al. Increasing Incidence of Paediatric Inflammatory Bowel Disease in Northern Stockholm County, 2002–2007 , 2013, Journal of pediatric gastroenterology and nutrition.
[69] A. Amiot,et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. , 2009, Gastroenterology.
[70] D. Jewell,et al. Role of the faecal stream in the maintenance of Crohn's colitis. , 1985, Gut.
[71] G. Greenberg,et al. Ustekinumab induction and maintenance therapy in refractory Crohn's disease. , 2012, The New England journal of medicine.
[72] G. Raimondo,et al. Celiac Disease and Non-organ-specific Autoantibodies in Patients with Chronic Hepatitis C Virus Infection , 2008, Digestive Diseases and Sciences.
[73] E. Szigethy,et al. Inflammatory bowel disease. , 2011, Pediatric clinics of North America.
[74] E. Loftus. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. , 2004, Gastroenterology.
[75] R. Panaccione,et al. Review: Efficacy and safety of adalimumab in Crohn's disease , 2008, Therapeutic advances in gastroenterology.
[76] S. Targan,et al. A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease , 1997 .
[77] C. Elson,et al. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota , 2005, Immunological reviews.
[78] Y. Sanz,et al. Unraveling the Ties between Celiac Disease and Intestinal Microbiota , 2011, International reviews of immunology.
[79] Lu Shan,et al. Structural Basis for Gluten Intolerance in Celiac Sprue , 2002, Science.
[80] E. Lindberg,et al. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. , 2003, Gastroenterology.
[81] H. Freeman. Application of the Montreal classification for Crohn's disease to a single clinician database of 1015 patients. , 2001, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[82] M. Rewers,et al. Rotavirus Infection Frequency and Risk of Celiac Disease Autoimmunity in Early Childhood: A Longitudinal Study , 2006, The American Journal of Gastroenterology.
[83] J. Scolapio,et al. Increased Prevalence and Mortality in Undiagnosed Celiac Disease , 2009 .
[84] S. Ghosh,et al. Serum IgA tissue transglutaminase antibodies in coeliac disease and other gastrointestinal diseases. , 2001, QJM : monthly journal of the Association of Physicians.
[85] A. Schäffer,et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. , 2009, The New England journal of medicine.
[86] J. Murray,et al. Prevalence of Celiac Disease in At-Risk and Not-At-Risk Groups in the United States , 2003 .
[87] J. Schulzke,et al. Randomized, Double Blind Controlled Trial of Subcutaneous Recombinant Human Interleukin-11 Versus Prednisolone in Active Crohn's Disease , 2006, The American Journal of Gastroenterology.
[88] D. Schuppan,et al. Monitoring nonresponsive patients who have celiac disease. , 2006, Gastrointestinal endoscopy clinics of North America.
[89] David C. Wilson,et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.